Gujarat Inject (Kerala) Peer Comparison

Gujarat Inject (Kerala) Ltd. stands out in a challenging position within the Pharmaceuticals & Drugs sector, exhibiting no revenue growth, profitability, or efficiency metrics, which contrasts sharply with its peers. Most competitors show significant growth and profitability, indicating Gujarat Inject's struggles relative to the sector.

• • Gujarat Inject has 0% revenue growth YoY and over 3 years.
• • The company has no reported EPS, ROE, or ROA metrics, implying a lack of profitability.
• • Compared to peers, Gujarat Inject's valuation metrics are less favorable with a high PE ratio but no earnings.
• • Financially, Gujarat Inject is in a precarious state with no debt and no returns.

• • Mankind Pharma Ltd.: Strong revenue growth of 18.12% YoY and solid profitability with an ROE of 23.15%.
• • Sun Pharmaceutical Industries Ltd.: Consistent growth with 8.42% YoY revenue increase and robust ROE of 16.13%.
• • Cipla Ltd.: Efficient operations reflected in high ROE at 16.63% and low debt levels.